MiRNA-139-3p inhibits malignant progression in urothelial carcinoma of the bladder via targeting KIF18B and inactivating Wnt/beta-catenin pathway Article

Zhang, Wenbin, Liu, Zhihua. (2023). MiRNA-139-3p inhibits malignant progression in urothelial carcinoma of the bladder via targeting KIF18B and inactivating Wnt/beta-catenin pathway . 33(1), 1-9. 10.1097/FPC.0000000000000485

cited authors

  • Zhang, Wenbin; Liu, Zhihua

authors

publication date

  • January 1, 2023

keywords

  • Biotechnology & Applied Microbiology
  • CANCER
  • Genetics & Heredity
  • KIF18B
  • Life Sciences & Biomedicine
  • METASTASIS
  • NEOADJUVANT CHEMOTHERAPY
  • PROLIFERATION
  • Pharmacology & Pharmacy
  • Science & Technology
  • Wnt
  • beta-catenin
  • bladder urothelial carcinoma
  • malignant progression
  • miRNA-139-3p

Digital Object Identifier (DOI)

publisher

  • LIPPINCOTT WILLIAMS & WILKINS

start page

  • 1

end page

  • 9

volume

  • 33

issue

  • 1